26 Aug 2021 --- Evolva has reported accelerated revenue growth in its half-year 2021 results, bolstered by “ongoing strong momentum” in Health Ingredients. On a reported basis, total revenue increased to CHF 6.4 million (US$6.9 million) from CHF 4 million (US$4.3 million), an increase of 60 percent. Product-related revenue increased to CHF 6.0 million from CHF 3.8 million (US$4.1 million), up by 58 percent in line with plans.
